Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06483217 · ClinicalTrials.gov registry record · NA
Optimal Injection Interval for Intra-Detrusor Botulinum Toxin
A NA study, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT06483217: Clinical Trial NA study, sponsored by Louisiana State University Health Sciences Center in New Orleans.
NCT06483217 is a NA study that has not yet begun recruiting, run by Louisiana State University Health Sciences Center in New Orleans. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06483217, a NA study, has not yet begun recruiting, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to see if patients deciding their own follow up times can increase the effectiveness of botulinum toxin (BTX or "Botox") injection for overactive bladder (OAB). The main questions it aims to answer are: * Does the time between repeat injections differ from the 6-month standard when it is based on patient symptoms alone? * Does symptom control or patient satisfaction change when patients control their own follow up times? Participants will undergo standard botulinum toxin injection into the bladder for OAB treatment and will then be randomly assigned to follow up either at a standard 6-month interval or whenever they feel their symptoms return.
Interventions
- BEHAVIORAL Patient-directed follow up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-07 |
| Est. Completion | 2025-10 |
| Phase | NA |
What is known before NCT06483217 opens enrollment
NCT06483217 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Patient-directed follow up is the first listed.
NCT06483217 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06483217 about?
NCT06483217 is a clinical study titled "Optimal Injection Interval for Intra-Detrusor Botulinum Toxin". The goal of this clinical trial is to see if patients deciding their own follow up times can increase the effectiveness of botulinum toxin (BTX or "Botox") injection for overactive bladder (OAB). The main questions it aims to answer are: * Does the time between repeat injections differ from the 6-m...
What is the current status of trial NCT06483217?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-07. Estimated completion is 2025-10.
What interventions are being tested in trial NCT06483217?
The interventions under investigation include: Patient-directed follow up (BEHAVIORAL).
Who is sponsoring clinical trial NCT06483217?
This trial is sponsored by Louisiana State University Health Sciences Center in New Orleans, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06483217's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia